Grail shares surge ahead of FDA advisory meeting on documents
Shares of Grail surged 34% after the FDA released documents ahead of a Wednesday advisory committee meeting on whether the company’s multi-cancer blood test will be approved.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.